Rock Springs Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-175,000
Closed -$7.56M 135
2015
Q3
$7.56M Buy
175,000
+7,000
+4% +$295K 0.61% 59
2015
Q2
$7.1M Hold
168,000
0.52% 73
2015
Q1
$6.51M Buy
168,000
+60,500
+56% +$2.33M 0.61% 56
2014
Q4
$3.62M Buy
107,500
+11,000
+11% +$389K 0.42% 73
2014
Q3
$3.38M Hold
96,500
0.52% 61
2014
Q2
$3.17M Buy
96,500
+44,000
+84% +$1.51M 0.57% 62
2014
Q1
$1.94M Buy
52,500
+19,000
+57% +$697K 0.45% 63
2013
Q4
$1.29M Buy
+33,500
New +$1.06M 0.46% 54

Other funds holding WX

Rock Springs Capital Management's WX Position: Q4 2015 in Review

Rock Springs Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 175,000 shares — an estimated $7.56M sold.

Rock Springs Capital Management first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $7.56M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Rock Springs Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Rock Springs Capital Management sold 175,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $7.56M.
  • Rock Springs Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
  • Rock Springs Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.56M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Rock Springs Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.